| 151 |
9667800 | Establishing the dose response curve for metabolic control with troglitazone, an insulin action enhancer, in type 2 diabetes patients. | 1998 Apr |
1 |
| 152 |
9709955 | Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-gamma. | 1998 Aug |
4 |
| 153 |
9727891 | Troglitazone use in insulin-treated type 2 diabetic patients. The Troglitazone Insulin Study Group. | 1998 Sep |
9 |
| 154 |
9727893 | Troglitazone reduces plasma leptin concentration but increases hunger in NIDDM patients. | 1998 Sep |
2 |
| 155 |
9737807 | Troglitazone, an insulin action enhancer, improves glycaemic control and insulin sensitivity in elderly type 2 diabetic patients. | 1998 Sep |
4 |
| 156 |
9745421 | Troglitazone monotherapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled study. The Troglitazone Study Group. | 1998 Sep |
1 |
| 157 |
9748292 | Thiazolidinediones inhibit lipoprotein lipase activity in adipocytes. | 1998 Oct 2 |
2 |
| 158 |
9752901 | Troglitazone, an insulin sensitizer, increases forearm blood flow in humans. | 1998 Sep |
2 |
| 159 |
9758309 | The role of troglitazone in treating the insulin resistance syndrome. | 1998 Sep-Oct |
3 |
| 160 |
9818203 | New therapeutic approaches to reversing insulin resistance. | 1998 Sep |
1 |
| 161 |
9824974 | Type 2 diabetes: glycemic targets and oral therapies for older patients. | 1998 Nov |
2 |
| 162 |
9844503 | Management of obesity in NIDDM (non-insulin-dependent diabetes mellitus). | 1998 Aug |
1 |
| 163 |
9845653 | Insulin action enhancement normalizes brachial artery vasoactivity in patients with peripheral vascular disease and occult diabetes. | 1998 Dec |
1 |
| 164 |
9925352 | Troglitazone ameliorates insulin resistance in a diabetic patient with Prader-Willi syndrome. | 1998 Dec |
3 |
| 165 |
15251737 | Troglitazone: current therapeutic role in type 2 diabetes mellitus. | 1998 Jul-Aug |
2 |
| 166 |
24393684 | Management of obesity in non- insulin- dependent diabetes mellitus. | 1998 Dec |
1 |
| 167 |
9032099 | Cardiac and glycemic benefits of troglitazone treatment in NIDDM. The Troglitazone Study Group. | 1997 Mar |
2 |
| 168 |
9054469 | Quantification of the effects of troglitazone on insulin sensitivity and beta-cell function in Watanabe heritable hyperlipidemic rabbits: a minimal model analysis. | 1997 Mar |
1 |
| 169 |
9075808 | Troglitazone reduces contraction by inhibition of vascular smooth muscle cell Ca2+ currents and not endothelial nitric oxide production. | 1997 Apr |
2 |
| 170 |
9118772 | Impaired glucose tolerance is normalized by treatment with the thiazolidinedione troglitazone. | 1997 Feb |
3 |
| 171 |
9186311 | Acute effect of troglitazone on glucose metabolism in the absence or presence of insulin in perfused rat hindlimb. | 1997 Jun |
16 |
| 172 |
9211083 | Troglitazone. | 1997 Jul |
4 |
| 173 |
9215280 | Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. | 1997 Jul |
2 |
| 174 |
9239399 | Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance. | 1997 Aug 1 |
2 |
| 175 |
9250189 | Efficacy of troglitazone measured by insulin resistance index. | 1997 Jul 19 |
1 |
| 176 |
9253306 | Troglitazone ameliorates insulin resistance in patients with Werner's syndrome. | 1997 Aug |
1 |
| 177 |
9284429 | [Treatment of hypertension associated with diabetes mellitus]. | 1997 Aug |
1 |
| 178 |
9284856 | Effects of troglitazone on insulin action and cardiovascular risk factors in patients with non-insulin-dependent diabetes. | 1997 Aug |
6 |
| 179 |
9347245 | Good metabolic and safety profile of troglitazone alone and following alcohol in NIDDM subjects. | 1997 Oct |
1 |
| 180 |
9371013 | New oral therapies for type 2 diabetes. | 1997 Nov 1 |
2 |
| 181 |
9392315 | Effect of troglitazone on blood insulin levels after pancreas transplantation with systemic venous drainage in rats. | 1997 Nov 27 |
4 |
| 182 |
9403322 | Perspective in the treatment of insulin resistance. | 1997 Oct |
2 |
| 183 |
9408053 | Monoclonal antibodies as surrogate receptors in a high throughput screen for compounds that enhance insulin sensitivity. | 1997 |
1 |
| 184 |
11229192 | Drug induced diabetes mellitus. | 1997 Nov |
2 |
| 185 |
15251787 | New therapeutic approaches to non-insulin-dependent diabetes mellitus. | 1997 Sep-Oct |
2 |
| 186 |
8740931 | New therapeutic agents for the treatment of NIDDM. | 1996 |
1 |
| 187 |
8772734 | Effect of troglitazone on leptin production. Studies in vitro and in human subjects. | 1996 Sep |
6 |
| 188 |
8781766 | Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group. | 1996 Jun |
4 |
| 189 |
8784087 | The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. | 1996 Sep |
7 |
| 190 |
8866563 | Effect of troglitazone on insulin sensitivity and pancreatic beta-cell function in women at high risk for NIDDM. | 1996 Nov |
6 |
| 191 |
8894499 | Effects of troglitazone on insulin sensitivity. | 1996 Sep |
2 |
| 192 |
8895337 | Troglitazone enhances differentiation, basal glucose uptake, and Glut1 protein levels in 3T3-L1 adipocytes. | 1996 Nov |
2 |
| 193 |
8914439 | [Drug therapy in subjects with impaired glucose tolerance]. | 1996 Oct |
4 |
| 194 |
8944206 | New treatments for patients with type 2 diabetes mellitus. | 1996 Nov |
1 |
| 195 |
7666790 | Acute effects of troglitazone on in vivo insulin action in normal rats. | 1995 Sep |
5 |
| 196 |
7794582 | Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives. | 1995 Mar |
3 |
| 197 |
8557288 | Special features of coronary heart disease in people of the Indian sub-continent. | 1995 Jul-Aug |
1 |
| 198 |
7935656 | Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. | 1994 Nov 3 |
3 |
| 199 |
1797492 | Effect of new oral antidiabetic agent CS-045 on glucose tolerance and insulin secretion in patients with NIDDM. | 1991 Nov |
1 |
| 200 |
3053303 | Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats. | 1988 Nov |
3 |